共 46 条
[1]
Chan W.M.(2004)Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series Ophthalmology 111 1576-1584
[2]
Lam D.S.(2007)Photodynamic therapy for age-related macular degeneration in Japanese patients: results after one year Jpn J Ophthalmol 51 210-215
[3]
Lai T.Y.(2007)Role of photodynamic therapy in polypoidal choroidal vasculopathy Jpn J Ophthalmol 51 270-277
[4]
Ogino T.(2008)One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients Ophthalmology 115 141-146
[5]
Takeda M.(2008)Two-year results of photodynamic therapy for polypoidal choroidal vasculopathy Am J Ophthalmol 146 513-519
[6]
Imaizumi H.(1997)The expanding clinical spectrum of idiopathic polypoidal choroidal vasculopathy Arch Ophthalmol 115 478-485
[7]
Okushiba U.(2004)Photodynamic therapy for age-related macular degeneration in a clinical setting: visual results and angiographic patterns Am J Ophthalmol 137 258-264
[8]
Akaza E.(2001)Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization—verteporfin in photodynamic therapy report 2 Am J Ophthalmol 131 541-560
[9]
Yuzawa M.(2003)Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report no. 1 Am J Ophthalmol 136 407-418
[10]
Matsumoto Y.(2006)Does lesion size determine the success rate of photodynamic therapy for age-related macular degeneration? Eye 20 43-45